Kurs & Likviditet
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Gothenburg, Sweden, November 14, 2022 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease, today announced that the company will participate at the LSX Inv€$tival Showcase in London, UK. The Showcase is part of Europe’s biggest dedicated healthcare investment week.
IRLAB will participate at the LSX Inv€$tival Showcase in London, UK, on November 14, 2022. The event's main purpose is to connect life science och healthcare executives with capital and partners and includes presentations and 1-1 meetings. The Show has an exclusive partnership with global investment bank Jefferies, with the showcase serving as the pre-day to Jefferies London Healthcare Conference.